Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many malignant tumors. However. ICI-induced hyper-immune activation causes cardiotoxicity. Traditional treatments such as glucocorticoids and immunosuppressants have limited effectiveness and may even accelerate tumor growth. https://parisnaturalfoodes.shop/product-category/rec-accel/